[Federal Register Volume 64, Number 142 (Monday, July 26, 1999)]
[Notices]
[Page 40401]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-19099]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Uniprime Capital Acceptance, Inc.; Order of Suspension of Trading

July 21, 1999.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Uniprime Capital Acceptance, Inc. (``Uniprime'') because of questions 
regarding the accuracy of statements by Uniprime to investors 
concerning, among other things, a product developed by a subsidiary for 
treating human immunodeficiency virus (HIV).
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to section 12(k) of the 
Securities Exchange Act of 1934, that trading in the above-listed 
company is suspended for the period from 9:30 a.m. EDT, July 22, 1999 
through 11:59 p.m. EDT, on August 4, 1999.

    By the Commission.
Jonathan G. Katz,
Secretary.
[FR Doc. 99-19099 Filed 7-22-99; 11:21 am]
BILLING CODE 8010-01-M